Pharmacists in Cedarville, Ohio


13 Pharmacists found in Cedarville
male pharmacist

Andrew M Straw, RPH


Pharmacist
251 N Main St, Cedarville, OH 45314
937-766-7498    

female pharmacist

Brenda Louise Pahl, PHARMD


Pharmacist
251 N Main Street, Hsc 234, Cedarville, OH 45314
937-766-7451    

female pharmacist

Janey Jarboe


Pharmacist
63 N Main St, Cedarville, OH 45314
937-766-2273    



male pharmacist

Dr. Jason A Baughman, PHARMD


Pharmacist
9 S Main St, Cedarville, OH 45314
937-766-9900     937-766-4766

male pharmacist

Prof. Jeffrey Huston, R.PH.


Pharmacist
251 N Main St, Cedarville, OH 45314
937-766-7486    

male pharmacist

Dr. John Edward Ballentine, PHARM.D.


Pharmacist
63 N Main St, Cedarville, OH 45314
937-766-7483    

female pharmacist

Dr. Juanita Ann Draime, PHARMD


Pharmacist
251 N Main St, Cedarville, OH 45314
937-766-3171    

female pharmacist

Dr. Katherine Perry, PHARMD


Pharmacist
63 N Main St, Cedarville, OH 45314
937-766-2273    

female pharmacist

Martha E Abraham, BSPS, PHARMD, RPH


Pharmacist
63 N Main St, Cedarville, OH 45314
937-766-2273    

male pharmacist

Dr. Mitchell Webber


Pharmacist
63 N Main St, Cedarville, OH 45314
937-766-2273    

female pharmacist

Mrs. Patricia Diane Sweeney, RPH


Pharmacist
63 N Main St, Cedarville, OH 45314
937-766-2273    

male pharmacist

Dr. Thaddeus Tyler Franz, PHARMD


Pharmacist - Clinician (PhC)/ Clinical Pharmacy Specialist
63 N Main St, Cedarville, OH 45314
937-766-2273     937-697-5086

female pharmacist

Dr. Tracy Frame, PHARM.D.


Pharmacist
251 N Main St, Cedarville, OH 45314
937-766-7426    


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.